Market Overview

Keefe, Bruyette & Woods Comments On eBay Q3 Results


Keefe, Bruyette & Woods maintained an Outperform rating and $65 price target on eBay Inc (NASDAQ: EBAY) in a report issued Thursday.

Analysts led by Sanjay Sakhrani lowered "2014 EPS estimate to $2.95 (from $2.97) to reflect slower growth at eBay as well as f/x headwinds, but are maintaining our 2015 and 2016 EPS estimates of $3.33 and $3.72, respectively."

Sakhrani noted that "3Q14 presented a number of challenges to companies from a macro and f/x perspective. For EBAY, this was compounded by additional issues unique to itself such as SEO and data breach impacts. Overall, we think that the company managed to post relatively resilient operating metrics for the quarter, though the outlook is somewhat softer than expected."

The report concluded that at "current levels, we believe that there is a fair amount of negativity baked into the shares and would be buyers on any weakness as ultimately, in our view, [the pending] separation of [eBay and PayPal] is likely to unlock value."

eBay Inc recently traded at $46.67, down 7 percent.

Latest Ratings for EBAY

Dec 2019MaintainsMarket Perform
Oct 2019MaintainsNeutral
Oct 2019MaintainsHold

View More Analyst Ratings for EBAY
View the Latest Analyst Ratings

Posted-In: Keefe Bruyette & Woods Sanjay SakhraniAnalyst Color Reiteration Analyst Ratings


Related Articles (EBAY)

View Comments and Join the Discussion!

Latest Ratings

TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

UPDATE: Pool Corp Q3 Earnings Meet Estimates

Will Actavis Win Competition For Allergan's Affection?